Amarin Corp ADR (AMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMRN | AMGN | GILD | VRTX | BIIB |
| Company | Amarin Corp ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.9672 | 300.12 | 65.57 | 413.33 | 218.00 |
| High | 0.9725 | 307.57 | 65.61 | 425.65 | 221.53 |
| Low | 0.8620 | 298.89 | 64.76 | 412.12 | 217.00 |
| Last | 0.8629 | 307.31 | 64.92 | 418.82 | 219.72 |
| Change | -0.1122 | +7.01 | -0.54 | +8.58 | +0.80 |
| % Change | -11.51% | +2.33% | -0.82% | +2.09% | +0.37% |
| Volume | 1,905,900 | 2,859,500 | 5,134,900 | 1,651,600 | 758,500 |
| 20-Day Average Volume | 1,041,705 | 2,869,700 | 7,463,450 | 1,133,780 | 1,370,295 |
| Previous Close | 0.9751 | 300.30 | 65.46 | 410.24 | 218.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9043 | 277.32 | 66.30 | 399.69 | 205.45 |
| 20-Day Raw Stochastic | 21.72% | 75.31% | 12.57% | 80.28% | 91.87% |
| 20-Day Relative Strength | 44.61% | 65.94% | 32.77% | 59.98% | 57.40% |
| Weighted Alpha | -42.20 | +32.33 | -21.04 | +21.35 | -26.82 |
| Today's Opinion | 64% Sell | 56% Buy | 100% Sell | 56% Buy | 56% Sell |
| Previous Opinion | Hold | 40% Buy | 100% Sell | 32% Buy | 56% Sell |
| Last Month's Opinion | 40% Buy | 8% Sell | 100% Sell | 24% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.81% since 05/01/24 | +10.79% since 05/01/24 | -0.90% since 05/01/24 | +4.15% since 05/01/24 | +1.66% since 05/01/24 |
| Low | 0.8130 on 05/02/24 | 274.90 on 05/02/24 | 64.33 on 05/03/24 | 394.03 on 05/07/24 | 213.11 on 05/03/24 |
| High | 1.0300 on 05/07/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 425.65 on 05/08/24 | 222.40 on 05/06/24 |
| 1-Month | |||||
| %Chg | -19.36% since 04/08/24 | +14.16% since 04/08/24 | -6.48% since 04/08/24 | +3.61% since 04/08/24 | +7.21% since 04/08/24 |
| Low | 0.8110 on 05/01/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 1.1100 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 425.65 on 05/08/24 | 222.40 on 05/06/24 |
| 3-Month | |||||
| %Chg | -29.85% since 02/08/24 | +4.23% since 02/08/24 | -12.03% since 02/08/24 | -1.00% since 02/08/24 | -8.56% since 02/08/24 |
| Low | 0.8015 on 03/14/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 1.3600 on 02/27/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 | 244.95 on 02/12/24 |
| 6-Month | |||||
| %Chg | +14.17% since 11/08/23 | +12.46% since 11/08/23 | -16.66% since 11/08/23 | +11.10% since 11/08/23 | -5.17% since 11/08/23 |
| Low | 0.6870 on 11/14/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 1.3700 on 01/30/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 400,446 | 161,091,424 | 81,502,736 | 106,030,224 | 31,874,096 |
| Shares Outstanding, K | 410,672 | 536,435 | 1,245,077 | 258,459 | 145,597 |
| Annual Sales | 306,910,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -59,110,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 56,520,000 | 7,447,000,000 | 6,686,000,000 | 2,517,700,000 | 2,290,500,000 |
| Last Quarter Net Income | -9,950,000 | -113,000,000 | -4,170,000,000 | 968,800,000 | 393,400,000 |
| 60-Month Beta | 1.96 | 0.60 | 0.22 | 0.39 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 05/01/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.08 | 16.26 | 26.73 | 14.76 |